Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Queensland Health
US Army
Covington
QuintilesIMS
Dow
AstraZeneca
Julphar

Generated: June 25, 2018

DrugPatentWatch Database Preview

CISAPRIDE MONOHYDRATE - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for cisapride monohydrate and what is the scope of cisapride monohydrate patent protection?

Cisapride monohydrate
is the generic ingredient in two branded drugs marketed by Janssen Pharms and Janssen Pharma, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for cisapride monohydrate.
Summary for CISAPRIDE MONOHYDRATE
Medical Subject Heading (MeSH) Categories for CISAPRIDE MONOHYDRATE
Synonyms for CISAPRIDE MONOHYDRATE
(R,S)-CISAPRIDE MONOHYDRATE
260779-88-2
30389-EP2301540A1
30389-EP2305652A2
30389-EP2311464A1
3553AH
4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide hydrate
4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide hydrate
AC1LCVEJ
AC1OCEJB
ACT02664
AKOS030612393
Ambap81098-60-4
API0002034
Benzamide, 4-amino-5-chloro-N-((3R,4S)-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxy-, hydrate (1:1), rel-
Benzamide, 4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxy-, cis monohydrate
Benzamide, 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxy-, cis- cis-4-Amino-5-chloro-N-[1-[3-(p-fluorophenoxy)propyl]-3-methoxy-4-piperidyl]-o-anisamide hydrate
C23H29ClFN3O4.H2O
CCG-100794
CHEMBL1200788
CHEMBL1546244
cis-4-amino-5-chloro-N-[1-[3-(4-fluoro-phenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide monohydrate
cis-4-Amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenxamide monohydrate
cis-4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide monohydrate
Cisapride (JAN)
Cisapride hydrate
Cisapride monohydrate [Orange Book]
Cisapride monohydrate, >=98% (HPLC), solid
Cisapride, United States Pharmacopeia (USP) Reference Standard
CISAPRIDEMONOHYDRATE
CPD000449272
CTK8E8558
D02092
HE070054
HE329654
HMS2051G13
HMS3393G13
KS-00001868
MFCD03305346
MLS000758247
MLS001423985
MLS003899196
MolPort-016-638-372
MolPort-044-674-489
NC00044
Propulsid (TN)
QBYYXIDJOFZORM-IKGOIYPNSA-N
RT-012057
s4751
SAM001246975
SCHEMBL220352
SCHEMBL467063
SCHEMBL467064
SCHEMBL9721799
SMR000449272
SMR002543365
UNII-VZV0A4I38W component QBYYXIDJOFZORM-IKGOIYPNSA-N
UNII-VZV0A4I38W component QBYYXIDJOFZORM-LBPAWUGGSA-N

US Patents and Regulatory Information for CISAPRIDE MONOHYDRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharma PROPULSID QUICKSOLV cisapride monohydrate TABLET, ORALLY DISINTEGRATING;ORAL 020767-001 Nov 7, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms PROPULSID cisapride monohydrate TABLET;ORAL 020210-001 Jul 29, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms PROPULSID cisapride monohydrate TABLET;ORAL 020210-002 Dec 23, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Janssen Pharms PROPULSID cisapride monohydrate SUSPENSION;ORAL 020398-001 Sep 15, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for CISAPRIDE MONOHYDRATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms PROPULSID cisapride monohydrate TABLET;ORAL 020210-001 Jul 29, 1993 ➤ Sign Up ➤ Sign Up
Janssen Pharms PROPULSID cisapride monohydrate SUSPENSION;ORAL 020398-001 Sep 15, 1995 ➤ Sign Up ➤ Sign Up
Janssen Pharma PROPULSID QUICKSOLV cisapride monohydrate TABLET, ORALLY DISINTEGRATING;ORAL 020767-001 Nov 7, 1997 ➤ Sign Up ➤ Sign Up
Janssen Pharms PROPULSID cisapride monohydrate TABLET;ORAL 020210-002 Dec 23, 1993 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
Cantor Fitzgerald
Cerilliant
McKinsey
Fuji
Cipla
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.